webinar register page

Neurological disorders associated with COVID-19: Neuropsychiatric and neurocognitive aspects in Australia and America
The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will review neuropsychiatric manifestations of COVID-19, and hear some preliminary results on the impact of COVID-19 on neurocognition and olfaction.

Speakers:

Chair: Professor Tom Solomon
Chair of Neurological Science, University of Liverpool, Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections

Dr James J. Sejvar, Centers for Disease Control and Prevention, United States of America
Neuropsychiatric manifestations of COVID-19

Dr Lucette Cysique & Prof Bruce J. Brew, St Vincent’s Hospital Applied Medical Research Centre, Australia
“ADAPT” COVID-19 Study: A prospective, observational cohort study at St Vincent’s Hospital Sydney: preliminary neurocognitive and olfaction results

Brain Infections Global: An NIHR Global Health Research Group on Improving the Management of Acute Brain Infections

Visit: https://braininfectionsglobal.tghn.org/

The Global Health Network's privacy policy: https://braininfectionsglobal.tghn.org/terms/privacy/

Aug 20, 2020 01:00 PM in London

Webinar logo
* Required information
Loading

Speakers

Prof Tom Solomon
@University of Liverpool, United Kingdom
Prof Tom Solomon is Director of the National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Head of the Brain Infections Group, Professor of Neurological Science, and Honorary Consultant Neurologist, Walton Centre NHS Foundation Trust and Royal Liverpool University Hospital.
Dr James J. Sejvar
@Centers for Disease Control and Prevention, United States of America
Dr Sejvar is a neurologist and epidemiologist at the U.S. Centers for Disease Control and Prevention (CDC). After completing undergraduate studies at Case Western Reserve University, he received his MD from Dartmouth Medical School in 1996, internal medicine training at Pittsburgh’s Mercy Medical Center, and completed a residency in neurology at the Mayo Clinic. He joined CDC in 2000, and is currently based at the Division of High-Consequence Pathogens and Pathology of the National Center for Emerging and Zoonotic Infectious Diseases. His research interests focus on the epidemiology, clinical manifestations and outcome of infections of the central nervous system. He has been has been working on COVID-19 since early January when the first reports of illness were announced in China.
Dr Lucette Cysique & Prof Bruce J. Brew
@St Vincent’s Hospital Applied Medical Research Centre, Australia
Dr Lucette Cysique is a neuropsychologist, specialist in brain imaging and Senior Lecturer at the University of New South Wales (UNSW) Sydney. Her research interests are conditions and factors that are relevant to the global HIV epidemic such as cognitive function, mental health and the effects of alcohol on the brain. Prof Bruce J. Brew is a Consultant Physician and Neurologist. He is a Professor of Medicine at UNSW and the University of Notre Dame Sydney. He is the Head of the Neurosciences Program and the Peter Duncan Neurosciences Unit at the St Vincent’s Centre for Applied Medical Research and the President of the International Society for Neurovirology. His main research interest is HIV related dementia and its pathogenesis. Dr Cysique is an Associated Investigator and Prof Brew the study neurology Principal Investigator for the “ADAPT” COVID-19 Study.